Abou-Hatab K, O'Mahony M S, Patel S, Woodhouse K
Department of Geriatric Medicine, Academic Centre, Llandough Hospital, Penarth, UK.
Age Ageing. 2001 Jan;30(1):41-5. doi: 10.1093/ageing/30.1.41.
the older population is the most medicated. Despite high drug usage, older people are generally excluded from the research underpinning new drug development. This means that drugs are prescribed to older people with very little understanding of how they are likely to metabolize them. More research is needed to investigate the possible effects of ageing on the biotransformation of drugs. We therefore undertook a cross-sectional study examining the effect of age on the activities of benzoylcholinesterase, butyrylcholinesterase, acetylcholinesterase and aspirin esterase.
we measured the activities of benzoylcholinesterase and butyrylcholinesterase in 70 healthy volunteers aged 18-85 years. We measured the activities of acetylcholinesterase and aspirin esterase in 43 healthy volunteers aged 18-85 years. We determined plasma activities of benzoylcholinesterase, butyrylcholinesterase, acetylcholinesterase and aspirin esterase spectrophotometrically.
we found no correlation between the activities of any of the enzymes measured and advancing age.
age per se is not associated with reductions in the activities of esterase enzymes.
老年人群用药量最大。尽管用药量高,但老年人通常被排除在支持新药研发的研究之外。这意味着在给老年人开药时,对药物在他们体内可能的代谢方式了解甚少。需要更多研究来调查衰老对药物生物转化可能产生的影响。因此,我们开展了一项横断面研究,以检验年龄对苯甲酰胆碱酯酶、丁酰胆碱酯酶、乙酰胆碱酯酶和阿司匹林酯酶活性的影响。
我们测量了70名年龄在18至85岁之间的健康志愿者体内苯甲酰胆碱酯酶和丁酰胆碱酯酶的活性。我们测量了43名年龄在18至85岁之间的健康志愿者体内乙酰胆碱酯酶和阿司匹林酯酶的活性。我们采用分光光度法测定血浆中苯甲酰胆碱酯酶、丁酰胆碱酯酶、乙酰胆碱酯酶和阿司匹林酯酶的活性。
我们发现所测的任何一种酶的活性与年龄增长之间均无相关性。
年龄本身与酯酶活性降低无关。